We are heartened by the global progress made with efforts to prevent and treat malaria, and by the commitment made by world leaders and governments to fund those efforts so that we may see a world without malaria within our...
Our ambition to eradicate malaria through developing SALVA!, the world’s first saliva-based rapid diagnostic test has moved a step closer after winning the 2019 Africa Challenge and a 3,000 EUR funding prize. This has also allowed us to book a...
We are proud to be an Africa Challenge Finalist...
The eradication of malaria has been given a boost following a grant of more than £1 Million ($ 1,299,161, ¥ 138,269,665) from Japan’s Global Health Innovative Technology (GHIT) Fund to facilitate the production, testing and validation trials of the world’s...
We’re pleased to announce we have received a €288 000 foundation grant from the De Beers Group to support our Saliva-based Malaria Asymptomatic and Asexual Rapid Test (SMAART) test, known as SALVA!, the world’s first ever saliva-based rapid diagnostic test...
“Spit here, please.” Will this become the instruction we receive upon entering clinics, schools, apothecaries and ports of entry throughout the globe? One of the main factors enabling the continued transmission of malaria are individuals who are free from symptoms...
(SALSI) January 31-February 2nd 2019, Chennai, India 7 February 2019: Dr Benji Pretorius, Founder and Managing Director of ERADA Technology Alliance (ERADA), presented news of a ground breaking non-invasive, saliva-based rapid diagnostic test for malaria, to a global audience of...
How targeting subclinical populations with a rapid saliva test may aid in the quest to eradicate the disease Jonathan James Efforts to eradicate certain infectious diseases, such as smallpox and polio, have generally proven fruitful – but one devastating infection...
